login
login
Image header Agence Europe
Europe Daily Bulletin No. 9406
Contents Publication in full By article 28 / 32
ECONOMIC INTERPENETRATION / (eu) pharmaceuticals

The Swiss pharmaceuticals group Roche has announced its plans to buy the American BioVeris, a specialist in immunochemistry quoted on the NASDAQ index, for $600 million. The price has been set at $21.4 per share. The transaction will open up a new market, estimated at €250 million, to Roche.

Contents

A LOOK BEHIND THE NEWS
THE DAY IN POLITICS
GENERAL NEWS
TIMETABLE
ECONOMIC INTERPENETRATION